Clinical trials: Chronic Persistent Vascular Facial Erythema
Chronic Persistent Vascular Facial Erythema
A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema.
This study evaluates the efficacy of Mirvaso® in the treatment of chronic persistent vascular facial erythema, after 4 weeks of treatment, by the Clinician erythema assessment.
- Trial name
- BR14004 (NCT02856919)
- Testing
- brimonidine tartrate
- Where
- 5 sites in Brazil
- Volunteers
- 101 people
- Sponsor
- Galderma Brasil Ltda.